Symbols / PLRZ Stock $16.12 -1.35% Polyrizon Ltd.
PLRZ (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
- Nasal barrier tech: how Polyrizon wants to plug gaps before vaccines - Stock Titan Mon, 11 May 2026 11
- PLRZ Stock Price and Chart — NASDAQ:PLRZ - TradingView hu, 04 Dec 2025 08
- $PLRZ stock is up 8% today. Here's what we see in our data. - Quiver Quantitative ue, 21 Apr 2026 07
- We Think Polyrizon (NASDAQ:PLRZ) Can Afford To Drive Business Growth - Yahoo Finance Fri, 05 Dec 2025 08
- TradingKey - TradingKey Mon, 11 May 2026 17
- Single investor commits $3.5M to Polyrizon in stock-warrant deal - Stock Titan ue, 07 Apr 2026 07
- This Former Penny Stock Just Doubled for the Second Time This Week. Should You Chase the Rally Here? - Yahoo Finance Fri, 05 Dec 2025 08
- Polyrizon pushes allergy and viral nasal blockers toward U.S. trials - Stock Titan hu, 26 Mar 2026 07
- Polyrizon raises $3.5M in stock sale for working capital - Stock Titan Wed, 08 Apr 2026 07
- Polyrizon widens U.S. patent bid to cover how nasal drugs stay put - Stock Titan Mon, 04 May 2026 12
- [EFFECT] Polyrizon Ltd. SEC Filing - Stock Titan ue, 05 May 2026 10
- Polyrizon seeks Europe patent for system designed to keep nasal drugs in place - Stock Titan Mon, 27 Apr 2026 07
- Polyrizon (Nasdaq: PLRZ) expands U.S. patent claims for intranasal drug delivery platform - Stock Titan Mon, 04 May 2026 12
- Polyrizon (Nasdaq: PLRZ) scales up PL-14 nasal spray production for 2026 trial - Stock Titan ue, 02 Dec 2025 08
- MMCAP, MM Asset Mgmt (PLRZ) joint filing reports 7.3% ownership - Stock Titan ue, 28 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
5.79
+344.32%
|
1.30
+105.04%
|
0.64
-29.05%
|
0.90
|
| Research And Development |
|
2.13
+299.44%
|
0.53
+60.84%
|
0.33
-4.32%
|
0.35
|
| Selling General And Administration |
|
3.65
+375.52%
|
0.77
+153.47%
|
0.30
-44.71%
|
0.55
|
| Selling And Marketing Expense |
|
—
|
0.00
|
0.00
-100.00%
|
0.01
|
| General And Administrative Expense |
|
3.65
+375.52%
|
0.77
+153.47%
|
0.30
-43.15%
|
0.53
|
| Salaries And Wages |
|
1.13
+596.30%
|
0.16
-3.57%
|
0.17
-11.58%
|
0.19
|
| Other Gand A |
|
2.52
+316.50%
|
0.61
+348.89%
|
0.14
-60.64%
|
0.34
|
| Total Expenses |
|
5.79
+344.32%
|
1.30
+105.04%
|
0.64
-29.05%
|
0.90
|
| Operating Income |
|
-5.79
-344.32%
|
-1.30
-105.04%
|
-0.64
+29.05%
|
-0.90
|
| Total Operating Income As Reported |
|
-6.25
-379.95%
|
-1.30
-105.04%
|
-0.64
+29.05%
|
-0.90
|
| EBITDA |
|
-5.44
-359.71%
|
-1.18
-87.64%
|
-0.63
+29.10%
|
-0.89
|
| Normalized EBITDA |
|
-10.67
-1000.72%
|
-0.97
-8.15%
|
-0.90
+8.76%
|
-0.98
|
| Reconciled Depreciation |
|
0.34
+189.83%
|
0.12
+2850.00%
|
0.00
-20.00%
|
0.01
|
| EBIT |
|
-5.79
-344.32%
|
-1.30
-105.04%
|
-0.64
+29.05%
|
-0.90
|
| Total Unusual Items |
|
5.22
+2529.30%
|
-0.21
-181.13%
|
0.27
+188.04%
|
0.09
|
| Total Unusual Items Excluding Goodwill |
|
5.22
+2529.30%
|
-0.21
-181.13%
|
0.27
+188.04%
|
0.09
|
| Special Income Charges |
|
-0.46
|
—
|
—
|
—
|
| Other Special Charges |
|
0.46
|
—
|
—
|
—
|
| Net Income |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Pretax Income |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Net Non Operating Interest Income Expense |
|
-2.77
-9803.57%
|
-0.03
+87.83%
|
-0.23
-1058.33%
|
0.02
|
| Net Interest Income |
|
-2.77
-9803.57%
|
-0.03
+87.83%
|
-0.23
-1058.33%
|
0.02
|
| Interest Income Non Operating |
|
0.37
|
0.00
|
0.00
|
—
|
| Interest Income |
|
0.37
|
0.00
|
0.00
|
—
|
| Other Income Expense |
|
5.22
+2529.30%
|
-0.21
-181.13%
|
0.27
+188.04%
|
0.09
|
| Gain On Sale Of Security |
|
5.69
+2745.12%
|
-0.21
-181.13%
|
0.27
+188.04%
|
0.09
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Net Income From Continuing And Discontinued Operation |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Net Income Continuous Operations |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Normalized Income |
|
-8.56
-543.46%
|
-1.33
-53.76%
|
-0.86
+0.69%
|
-0.87
|
| Net Income Common Stockholders |
|
-3.33
-107.79%
|
-1.60
-139.91%
|
-0.67
+18.71%
|
-0.82
|
| Diluted EPS |
|
—
|
-805.20
-236.52%
|
-239.27
+18.71%
|
-294.35
|
| Basic EPS |
|
—
|
-805.20
-236.52%
|
-239.27
+18.71%
|
-294.35
|
| Basic Average Shares |
|
—
|
0.00
-28.68%
|
0.00
+0.00%
|
0.00
|
| Diluted Average Shares |
|
—
|
0.00
-28.68%
|
0.00
+0.00%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-3.33
-107.79%
|
-1.60
-139.91%
|
-0.67
+18.71%
|
-0.82
|
| Preferred Stock Dividends |
|
—
|
0.06
-13.04%
|
0.07
+56.82%
|
0.04
|
| Total Other Finance Cost |
|
3.14
+11125.00%
|
0.03
-87.83%
|
0.23
+1058.33%
|
-0.02
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
21.44
+286.46%
|
5.55
+892.31%
|
0.56
+2.38%
|
0.55
|
| Current Assets |
|
12.86
+384.73%
|
2.65
+4812.96%
|
0.05
+5.88%
|
0.05
|
| Cash Cash Equivalents And Short Term Investments |
|
12.46
+388.02%
|
2.55
+6129.27%
|
0.04
+13.89%
|
0.04
|
| Cash And Cash Equivalents |
|
1.31
-48.86%
|
2.55
+63750.00%
|
0.00
-88.89%
|
0.04
|
| Other Short Term Investments |
|
11.16
|
0.00
-100.00%
|
0.04
|
0.00
|
| Other Current Assets |
|
0.40
+300.00%
|
0.10
+661.54%
|
0.01
-13.33%
|
0.01
|
| Total Non Current Assets |
|
8.58
+196.37%
|
2.89
+473.07%
|
0.51
+2.02%
|
0.49
|
| Net PPE |
|
0.01
+20.00%
|
0.01
-16.67%
|
0.01
-25.00%
|
0.02
|
| Goodwill And Other Intangible Assets |
|
2.55
-11.69%
|
2.88
|
0.00
|
—
|
| Non Current Deferred Assets |
|
—
|
0.00
-100.00%
|
0.49
+2.92%
|
0.48
|
| Non Current Prepaid Assets |
|
6.02
|
0.00
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
0.44
+69.73%
|
0.26
-65.20%
|
0.75
-48.13%
|
1.45
|
| Current Liabilities |
|
0.44
+69.73%
|
0.26
-48.01%
|
0.50
-58.10%
|
1.20
|
| Payables And Accrued Expenses |
|
0.29
+36.11%
|
0.22
+36.71%
|
0.16
+12.06%
|
0.14
|
| Current Accrued Expenses |
|
0.29
+36.11%
|
0.22
+36.71%
|
0.16
+12.06%
|
0.14
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.15
+231.11%
|
0.04
+15.38%
|
0.04
+5.41%
|
0.04
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
0.20
-67.85%
|
0.62
|
| Current Debt |
|
—
|
—
|
0.20
-67.85%
|
0.62
|
| Other Current Borrowings |
|
—
|
—
|
0.20
-67.85%
|
0.62
|
| Other Current Liabilities |
|
—
|
—
|
0.10
-73.62%
|
0.40
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
0.00
-100.00%
|
0.25
+0.00%
|
0.25
|
| Preferred Securities Outside Stock Equity |
|
—
|
0.00
-100.00%
|
0.25
+0.00%
|
0.25
|
| Stockholders Equity |
|
20.99
+297.16%
|
5.29
+2867.54%
|
-0.19
+78.78%
|
-0.90
|
| Common Stock Equity |
|
20.99
+297.16%
|
5.29
+2867.54%
|
-0.19
+78.78%
|
-0.90
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
1.61
+57420.24%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Ordinary Shares Number |
|
1.61
+57420.24%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Additional Paid In Capital |
|
29.39
+183.95%
|
10.35
+193.59%
|
3.53
+74.47%
|
2.02
|
| Retained Earnings |
|
-8.40
-65.83%
|
-5.07
-43.88%
|
-3.52
-20.54%
|
-2.92
|
| Total Equity Gross Minority Interest |
|
20.99
+297.16%
|
5.29
+2867.54%
|
-0.19
+78.78%
|
-0.90
|
| Total Capitalization |
|
20.99
+297.16%
|
5.29
+2867.54%
|
-0.19
+78.78%
|
-0.90
|
| Working Capital |
|
12.42
+419.11%
|
2.39
+633.93%
|
-0.45
+60.94%
|
-1.15
|
| Invested Capital |
|
20.99
+297.16%
|
5.29
+58633.33%
|
0.01
+103.24%
|
-0.28
|
| Total Debt |
|
—
|
—
|
0.20
-67.85%
|
0.62
|
| Net Debt |
|
—
|
—
|
0.20
-66.55%
|
0.59
|
| Net Tangible Assets |
|
18.45
+667.99%
|
2.40
+1357.59%
|
-0.19
+78.78%
|
-0.90
|
| Tangible Book Value |
|
18.45
+667.99%
|
2.40
+1357.59%
|
-0.19
+78.78%
|
-0.90
|
| Other Equity Interest |
|
—
|
—
|
-0.20
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.53
-294.77%
|
-1.15
-113.59%
|
-0.54
+52.56%
|
-1.13
|
| Cash Flow From Continuing Operating Activities |
|
-4.53
-294.77%
|
-1.15
-113.59%
|
-0.54
+52.56%
|
-1.13
|
| Net Income From Continuing Operations |
|
-3.33
-115.86%
|
-1.54
-157.50%
|
-0.60
+22.98%
|
-0.78
|
| Depreciation Amortization Depletion |
|
0.34
+189.83%
|
0.12
+2850.00%
|
0.00
-20.00%
|
0.01
|
| Depreciation |
|
—
|
0.12
+2850.00%
|
0.00
-20.00%
|
0.01
|
| Depreciation And Amortization |
|
0.34
+189.83%
|
0.12
+2850.00%
|
0.00
-20.00%
|
0.01
|
| Other Non Cash Items |
|
2.46
+7825.81%
|
0.03
-86.40%
|
0.23
+976.92%
|
-0.03
|
| Stock Based Compensation |
|
1.31
+2468.63%
|
0.05
-49.00%
|
0.10
-23.08%
|
0.13
|
| Operating Gains Losses |
|
-5.14
-2537.91%
|
0.21
+172.01%
|
-0.29
-148.31%
|
-0.12
|
| Gain Loss On Investment Securities |
|
-5.14
-2537.91%
|
0.21
+172.01%
|
-0.29
-148.31%
|
-0.12
|
| Unrealized Gain Loss On Investment Securities |
|
0.00
-100.00%
|
0.01
-52.94%
|
0.02
|
0.00
|
| Change In Working Capital |
|
-0.16
-652.38%
|
-0.02
-400.00%
|
0.01
+102.03%
|
-0.34
|
| Change In Payables And Accrued Expense |
|
0.04
-39.66%
|
0.06
+241.18%
|
0.02
+213.33%
|
-0.01
|
| Change In Accrued Expense |
|
0.04
-39.66%
|
0.06
+241.18%
|
0.02
+213.33%
|
-0.01
|
| Change In Other Working Capital |
|
0.10
+1633.33%
|
0.01
+150.00%
|
-0.01
+96.42%
|
-0.34
|
| Change In Other Current Assets |
|
-0.30
-249.41%
|
-0.09
-4350.00%
|
0.00
-66.67%
|
0.01
|
| Investing Cash Flow |
|
-16.53
-57113.79%
|
0.03
|
0.00
+100.00%
|
-0.00
|
| Cash Flow From Continuing Investing Activities |
|
-16.53
-57113.79%
|
0.03
|
0.00
+100.00%
|
-0.00
|
| Net PPE Purchase And Sale |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.00
|
| Purchase Of PPE |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.00
|
| Capital Expenditure |
|
-0.01
|
—
|
—
|
-0.00
|
| Net Investment Purchase And Sale |
|
-16.53
-57089.66%
|
0.03
|
0.00
|
0.00
|
| Purchase Of Investment |
|
-16.53
|
0.00
|
0.00
|
—
|
| Sale Of Investment |
|
0.00
-100.00%
|
0.03
|
0.00
|
0.00
|
| Financing Cash Flow |
|
19.81
+440.19%
|
3.67
+626.34%
|
0.51
-22.07%
|
0.65
|
| Cash Flow From Continuing Financing Activities |
|
19.81
+440.19%
|
3.67
+626.34%
|
0.51
-22.07%
|
0.65
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-0.01
-102.41%
|
0.25
-61.57%
|
0.65
|
| Issuance Of Debt |
|
0.00
-100.00%
|
0.31
+24.50%
|
0.25
-61.57%
|
0.65
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-0.32
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
0.31
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-0.32
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
+100.00%
|
-0.01
|
0.00
|
0.00
|
| Short Term Debt Issuance |
|
0.00
|
0.00
-100.00%
|
0.25
-61.57%
|
0.65
|
| Net Short Term Debt Issuance |
|
0.00
|
0.00
-100.00%
|
0.25
-61.57%
|
0.65
|
| Net Common Stock Issuance |
|
19.81
+439.30%
|
3.67
+1335.16%
|
0.26
|
0.00
|
| Changes In Cash |
|
-1.25
-148.94%
|
2.55
+8068.75%
|
-0.03
+93.43%
|
-0.49
|
| Beginning Cash Position |
|
2.55
+63750.00%
|
0.00
-88.89%
|
0.04
-93.12%
|
0.52
|
| End Cash Position |
|
1.31
-48.86%
|
2.55
+63750.00%
|
0.00
-88.89%
|
0.04
|
| Free Cash Flow |
|
-4.54
-295.38%
|
-1.15
-113.59%
|
-0.54
+52.69%
|
-1.14
|
| Common Stock Issuance |
|
19.81
+439.30%
|
3.67
+1335.16%
|
0.26
|
0.00
|
| Issuance Of Capital Stock |
|
19.81
+439.30%
|
3.67
+1335.16%
|
0.26
|
0.00
|
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|